Back to Market返回行情

A Agilent Technologies, Inc.

USHealthcare
$133.59+3.50%ClosedMarket Cap: $37.73B

As of 2026-07-09 16:01

Why A matters now

Agilent Technologies, Inc. (A) is a US stock in Healthcare. The latest InvestLog snapshot shows $133.59 with +3.50% on the session and $37.73B in market capitalization; recent performance reads 1-month +14.91% and YTD -6.62%.

The latest financial table shown here is Q2 2026, with revenue of $1.83B, net income of $339.0M, and EPS of $1.20. Investors can compare that operating picture with valuation signals such as P/E 24.97 and FCF yield 3.5%.

The latest indexable market news headline is "Agilent Strengthens Biopharma Growth Prospects With AI Expansion" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Buy with a median target of $156.50; recent insider activity includes MCDONNELL PADRAIG filing F-InKind. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

24.97

PEG

10.14

P/B

5.05

P/S

4.96

EV/EBITDA

19.08

DCF Value

$76.08

FCF Yield

3.5%

Div Yield

0.8%

Margins & Returns

Gross Margin

53.0%

Operating Margin

21.5%

Net Margin

19.6%

ROE

20.8%

ROA

10.8%

ROIC

12.5%

Financials

PeriodRevenueNet IncomeEPS
Q2 2026$1.83B$339.0M$1.20
Q1 2026$1.80B$305.0M$1.07
Q4 2025$1.86B$434.0M$1.53
FY 2025$6.95B$1.30B$4.57

Analyst Ratings

Consensus

Buy

Target (Consensus)

$154.75

Target (Median)

$156.50

Target Range

$140.00 - $165.00

Strong Buy: 5Buy: 11Hold: 3Sell: 0Strong Sell: 0
Piper SandlerNeutral
2026-06-11
HSBCBuy
2026-06-03
B of A SecuritiesBuy
2026-06-02
Wells FargoOverweight
2026-05-28
RBC CapitalOutperform
2026-05-28

Trading Activity

Insider Trades

MCDONNELL PADRAIGdirector, officer: President and CEO
Sell2026-06-05
Downs Timothy Charlesofficer: VP, Chief Accounting Officer
Sell2026-06-05
Dolsten Mikaeldirector
Sell2026-06-02
Buckner Michael Stevenofficer: Senior Vice President
Sell2026-05-21
MAY SIMONofficer: Senior Vice President
Sell2026-05-12

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

1.26

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.